Australia BCG vaccine effective against new type of coronavirus to clinical trial March 27 22:56
An Australian research institute has announced a clinical trial of a BCG vaccine used to prevent tuberculosis to confirm its efficacy against the new coronavirus.
According to Murdoch's Children's Research Institute in Melbourne, Southeast Australia, clinical trials will be conducted on 4,000 healthcare professionals across Australia.
BCG vaccines have been shown to increase human immune function, and previous studies have shown that using BCG vaccines in people infected with similar viruses can reduce the number of viruses. You.
The institute has hoped that if the vaccine's effectiveness is confirmed, it will save time before a vaccine specific to the new coronavirus can be developed.